HIPK1: a New Druggable Kinase Target for Treating Pathological Cardiac Hypertrophy

J Cardiovasc Transl Res. 2024 Feb;17(1):230-232. doi: 10.1007/s12265-023-10405-6. Epub 2023 Jun 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiomegaly / drug therapy
  • Humans
  • Myocytes, Cardiac
  • Protein Kinases*
  • Protein Serine-Threonine Kinases*

Substances

  • Protein Serine-Threonine Kinases
  • Protein Kinases
  • HIPK1 protein, human